Ginkgo Bioworks Holdings, Inc.
Biological Products, (No Diagnostic Substances) · 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
官方登記資料
0位追蹤者
2008成立於
關於 Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
成立時間2008
法律形式C Corporation
狀態營運中
關鍵數據
法律資訊
| 法定名稱 | Ginkgo Bioworks Holdings, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1830214在 SEC EDGAR 上查看 ↗ |
| EIN | 87-2652913 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面